Crohn Disease (CD) Clinical Trials

35 recruiting

Frequently Asked Questions

Common questions about Crohn Disease (CD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting

Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease

Crohn Disease (CD)
Sakarya University100 enrolled1 locationNCT07441447
Recruiting
Phase 2

HB-adMSCs for the Treatment of Crohn's Disease

Crohn Disease (CD)
Hope Biosciences Research Foundation46 enrolled1 locationNCT07077746
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled9 locationsNCT07245394
Recruiting

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

IBD (Inflammatory Bowel Disease)Crohn Disease (CD)IBS - Irritable Bowel Syndrome+1 more
American Laboratory Products Company120 enrolled1 locationNCT07089420
Recruiting
Not Applicable

Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study

Ulcerative Colitis (UC)Crohn Disease (CD)
IRCCS Ospedale San Raffaele80 enrolled1 locationNCT06896305
Recruiting
Not Applicable

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Crohn Disease (CD)
Alimentiv Inc.378 enrolled30 locationsNCT07363044
Recruiting

CEDUR - German IBD Registry

Ulcerative Colitis (UC)Crohn Disease (CD)Indeterminate Colitis
ImmunoRegister gUG10,000 enrolled1 locationNCT07319442
Recruiting
Phase 4

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Ulcerative Colitis (UC)Crohn Disease (CD)
McGill University Health Centre/Research Institute of the McGill University Health Centre115 enrolled1 locationNCT07303686
Recruiting

Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

Crohn Disease (CD)Transmural Response
University Hospital, Clermont-Ferrand100 enrolled4 locationsNCT07308067
Recruiting
Not Applicable

Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

Crohn Disease (CD)Ileocolic ResectionPost-endoscopic Operative Reccurence
University Hospital, Clermont-Ferrand42 enrolled8 locationsNCT06972901
Recruiting

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

Ulcerative Colitis (UC)Crohn Disease (CD)Autism Spectrum Disorder+6 more
Chen QiYi4,000 enrolled1 locationNCT07261826
Recruiting
Early Phase 1

Cranberry and Gut Health in Crohn's Disease

Crohn DiseaseCrohn Disease (CD)
Ana Maldonado-Contreras50 enrolled1 locationNCT07170462
Recruiting
Not Applicable

Evaluation of the SMART IBD App in Pediatric IBD

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)+3 more
Children's Hospital Medical Center, Cincinnati70 enrolled1 locationNCT07195123
Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+4 more
Connecticut Children's Medical Center120 enrolled1 locationNCT07224113
Recruiting

Laparoscopic Right Hemicolectomy for Crohn's Disease of the Terminal Ileum Utilizing the Mesenteric Excision and Exclusion

Crohn Disease (CD)Crohn Disease of IleumKono S Anastomosis+1 more
Tzaneio General Hospital50 enrolled1 locationNCT07231601
Recruiting
Phase 2

Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

Crohn Disease (CD)
Madeleine Bezault80 enrolled12 locationsNCT06925061
Recruiting
Not Applicable

TIDHI Mental Health in IBD Patients Study

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)
TIDHI Innovation Inc.100 enrolled1 locationNCT07013578
Recruiting

Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY

Crohn Disease (CD)
Fondazione Poliambulanza Istituto Ospedaliero180 enrolled1 locationNCT07111715
Recruiting

AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease

Crohn Disease (CD)
Minhu Chen234 enrolled5 locationsNCT06858553
Recruiting
Not Applicable

Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression

Crohn Disease (CD)
GLSMED Learning Health S.A.30 enrolled1 locationNCT06727253